Alvotech (ALVO)
14.40
-0.11
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
14.39
-0.01
(-0.07%)
After-Hours: 20:00
Alvotech Cash from Financing (TTM): 301.32M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 301.32M |
September 30, 2023 | 409.03M |
June 30, 2023 | 275.83M |
Date | Value |
---|---|
March 31, 2023 | 517.73M |
December 31, 2022 | 424.91M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
275.83M
Minimum
Jun 2023
517.73M
Maximum
Mar 2023
385.76M
Average
409.03M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
AbbVie Inc | -211.00M |
Teva Pharmaceutical Industries Ltd | -1.913B |
Moolec Science SA | 5.974M |
Procaps Group SA | -45.56M |
NeuroMetrix Inc | 2.325M |